Drug 411 News

Doctors Want Better Info From Pharma Reps

pharma reps technology

Pharma reps are failing to keep up with the digital age, according to analysis from a leading medical research firm. A new study just released by DRG Digital’s Manhattan Research indicates that pharma reps are showing doctors news that they’ve already seen. Poll respondents say that in more than half of the time (51%) the reps are…

Read More

Business as Usual After Martin Shkreli Conviction

There was a lot of hand wringing when so-called “Pharma Bro” Martin Shkreli was charged with 8 counts of wire and securities fraud in late 2015. Shkreli you may recall was the former wunderkind executive of Turing Pharmaceutical who decided to increase the price of the anti HIV/AIDS drug Daraprim by more than 5000% in…

Read More

Ransomware Hits U.S. Healthcare As Merck Is Attacked

ransomware us healthcare

Ransomware has been the buzzword on everyone’s lips this month, as hackers attack computer systems around the world. Despite the potentially fatal consequences, healthcare sectors around the world have not been spared from these attacks. Back in May, the UK suffered a serious disruption of its National Health Service (NHS) when malware known as “Wannacry”…

Read More

Researchers Take Steps to Reduce PPI Use

reduce ppi use

Following years of advice to curb the over-reliance on proton pump inhibitors (PPI), researchers are starting to take concrete steps to reduce PPI use.  The latest guidance for deprescribing PPIs was issued in Canada earlier this month, where researchers from the University of Ottawa in Ontario have used evidence from multiple clinical studies to assist…

Read More

An Ocean Away, Medical Device Regulations Save Lives

medical device regulations

Add the term “regulation” to almost any topic and the conversation is likely to become heated. When it comes to medical device regulations, however, the life and death nature of the discussion raises the stakes. Unfortunately, regulatory action in the United States usually places a distant second, at best. Pharmaceutical sector profit margins are the…

Read More

Will the Amazon Effect Reach the Pharmaceutical Sector?

mouse and drugs

The “Amazon effect” has impacted many industries over the years. From digitizing the world of books back in the nineties to turning the big box retail model on its head in recent years, any vertical the e-commerce giant touches typically gets disrupted.   Now, the pharmaceutical sector seems to be next in line… After several…

Read More

Prescription Drug Prices Soared Out of Control in 2016

prescription drug prices 2016

We all know that prescription drug prices are on the rise, but the pace of that acceleration is vastly out of step with nationwide inflation, according to new numbers from Truveris. The company compiles the National Drug Index, which tracks the price of the most commonly prescribed medications in the U.S. Results for 2016 continued…

Read More

Proposed Bill Could "Straight Jacket" Class Actions

house class action lawsuit bill

A new bill proposed by lawmakers threatens to stifle class actions and limit the few remaining protections defending consumers from large corporations, according to its critics. The Fairness in Class Action Litigation Act narrowly passed through the House of Representatives last week. It is a revised version of a less ambitious bill that failed to…

Read More

A Bipartisan Bill? Drug Prices Unite U.S. Politicians


In a political environment more charged than any other time in recent memory, issues that everyone can agree on are few and far between. Even against that divisive backdrop, however, there seems to be one problem that all parties want to tackle as soon as possible: inflated drug prices in the U.S.  As February came…

Read More